EDGEWISE THERAPEUTICS INC (EWTX) Stock Analyst Ratings
USA - NASDAQ:EWTX - US28036F1057 - Common Stock
22.05 USD
-0.2 (-0.9%)
ChartMill assigns a Buy % Consensus number of 82% to EWTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.07. This target is 63.59% above the current price.
EWTX was analyzed by 19 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about EWTX.
In the previous month the buy percentage consensus was at a similar level.
EWTX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-25 | Goldman Sachs | Initiate | Neutral |
| 2025-08-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-06-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-21 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-04-03 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-04-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-22 | Stifel | Initiate | Hold |
| 2024-12-17 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-11-27 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-22 | Evercore ISI Group | Initiate | Outperform |
| 2024-11-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-10-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-09-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-19 | Truist Securities | Maintains | Buy -> Buy |
| 2024-09-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-07-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-10 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-07-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-26 | Wedbush | Reiterate | Outperform -> Outperform |
EDGEWISE THERAPEUTICS INC / EWTX FAQ
What is the price target for EWTX stock?
19 analysts have analysed EWTX and the average price target is 36.07 USD. This implies a price increase of 63.59% is expected in the next year compared to the current price of 22.05.
Can you provide the consensus rating for EDGEWISE THERAPEUTICS INC stock?
The consensus rating for EDGEWISE THERAPEUTICS INC (EWTX) is 82.1053 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for EDGEWISE THERAPEUTICS INC stock?
The number of analysts covering EDGEWISE THERAPEUTICS INC (EWTX) is 19.